## Abstract Chronic pain presents a persistent and significant clinical challenge. Research examining commonly used psychotherapeutic treatments suggests that the results are not always well maintained, and that pain often is unrelieved. Continued exploration of new and more effective approaches is
Clinical considerations in the treatment of chronic pain with opiates
β Scribed by Bruce D. Naliboff; Stephen M. Wu; Quynh Pham
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 108 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0021-9762
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This article considers assessment and treatment issues for mental health practitioners working with patients using opiate medications to treat chronic pain with a particular emphasis on their potential relationship to substance abuse. We review general opiate medications, including a discussion of medications with increased addiction potential. Practice guidance is offered regarding longβterm opiate treatment, including definitions of addiction, initial assessments, ongoing substance misuse monitoring, use of psychological assessment instruments, and managing medication misuse problems. Additionally, we examine the role of the mental health professional within this area and examine the incorporation of psychological interventions for patients using opiates. A case illustration includes several of these complicated issues of managing chronic pain with opiate medications. Β© 2006 Wiley Periodicals, Inc. J Clin Psychol: In Session 62: 1397β1408, 2006.
π SIMILAR VOLUMES
this Book Showcases The Development And Evaluation Of Innovative Examples Of Pain Management Initiatives By Advanced Practitioners. It Considers Each Service Development Or Community Initiative Both In Terms Of Advanced Practice Nursing And Pain Management. There Is A Wide Range Of Examples Of Innov
## Background: Controlled-release (cr) morphine tablets have become routine therapy in the management of cancer pain. compared with immediate-release (ir) morphine, this formulation provides the benefit of dosing every 12 hours. ## Methods: This study reviewed the 10 published, well controlled, r